Prostate International

Papers
(The H4-Index of Prostate International is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
A review of social determinants of prostate cancer risk, stage, and survival60
Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients’ survival and responses to androgen deprivation therapies in Indonesian patients cohort26
Prostate diseases and microbiome in the prostate, gut, and urine26
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer24
Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer19
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review16
Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia15
Impact of surgically maximized versus native membranous urethral length on 30-day and long-term pad-free continence after robot-assisted radical prostatectomy14
Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study13
What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?13
Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies13
Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients13
Changes in diagnosis rate and treatment trends of benign prostatic hyperplasia in Korea: A nationwide population-based cohort study13
0.026798963546753